Shuttle Pharmaceuticals, Inc. logo

Shuttle Pharmaceuticals, Inc. Employee Directory

Biotechnology ResearchMaryland, United States2-10 Employees

Shuttle Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients treated with radiation therapy. Its therapeutic approach aims to sensitize cancer cells to radiation, promoting DNA damage and activating innate immune responses, with potential to combine with checkpoint inhibitors and other immune therapies. The company also operates a diagnostics business that seeks to predict clinical outcomes to guide treatment decisions for patients considering radiation therapy for prostate cancer. It is based in Rockville, Maryland, and targets clinicians and patients involved in radiation-based cancer treatment. 

The company is a small organization within the biotechnology research industry. In March 2026, Shuttle Pharmaceuticals announced a major advancement to its molecule.ai platform, signaling ongoing progress in AI-driven drug discovery.

Find Shuttle Pharmaceuticals, Inc. employees' phone numbers or email addresses

Shuttle Pharmaceuticals, Inc. Global Highlights

Location
Employees

North America
7

Minus sign iconPlus sign icon
  • United States Of America
    7

Europe
1

Minus sign iconPlus sign icon
  • Italy
    1

Shuttle Pharmaceuticals, Inc.'s Leadership

  • Chief Financial Officer at Shuttle Pharmaceuticals, Inc.
    T. L.
    Chief Financial Officer
  • Vp Regulatory at Shuttle Pharmaceuticals, Inc.
    M. V. H.
    Vp Regulatory
  • Co-Founder, Board Member at Shuttle Pharmaceuticals, Inc.
    M. B.
    Co-Founder, Board Member
  • Employee at Shuttle Pharmaceuticals, Inc.
    A. V.
  • Employee at Shuttle Pharmaceuticals, Inc.
    A. D.

Shuttle Pharmaceuticals, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Entrepreneurship
  • Biotechnology
  • Business
  • Education
  • Legal
  • Other

Contact profiles from Shuttle Pharmaceuticals, Inc.

Name
Title
Contact
Location
Last Update
  • Chief Financial Officer at Shuttle Pharmaceuticals, Inc.
    T. L.
    Chief Financial Officer
    United States
    May 30, 2026
  • Co-Founder, Board Member at Shuttle Pharmaceuticals, Inc.
    M. B.
    Co-Founder, Board Member
    United States
    Mar 11, 2026
  • Vp Regulatory at Shuttle Pharmaceuticals, Inc.
    M. V. H.
    Vp Regulatory
    United States, District of Columbia
    Jun 02, 2025
  • Employee at Shuttle Pharmaceuticals, Inc.
    A. V.
    UNITED STATES
    Mar 07, 2023
  • Employee at Shuttle Pharmaceuticals, Inc.
    A. D.
    UNITED STATES
    Aug 04, 2023

Frequently Asked Questions

What is Shuttle Pharmaceuticals, Inc. known for?

Minus sign iconPlus sign icon
Shuttle Pharmaceuticals, Inc. was founded in 2012 and operates in the Biotechnology Research industry. Explore Shuttle Pharmaceuticals, Inc.'s company overview page for more information.

What is Shuttle Pharmaceuticals, Inc.'s most common email format?

Minus sign iconPlus sign icon
Shuttle Pharmaceuticals, Inc. employees' email format typically follows the pattern of First.Last@shuttlepharma.org. Trying to find reliable and up-to-date employee contact data? Find more Shuttle Pharmaceuticals, Inc. email formats with LeadIQ.

How many employees does Shuttle Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
Shuttle Pharmaceuticals, Inc. has approximately 5 employees as of August 2026. These team members are located across 2 continents, including North America and Europe.

Who are Shuttle Pharmaceuticals, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Shuttle Pharmaceuticals, Inc.'s key employees include:

  • Chief Financial Officer: T. L.
  • Vp Regulatory: M. V. H.
  • Co-Founder, Board Member: M. B.
  • : A. V.
  • : A. D.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.